arrow
P

Praveen Surendran

University of Cambridge
H指数:48
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Proteomic signatures improve risk prediction for common and rare diseases

蛋白质组学特征改善了常见和罕见疾病的风险预测

2024-07-224
OA
Proteome-wide association study and functional validation identify novel protein markers for pancreatic ductal adenocarcinoma

全蛋白质组关联研究和功能验证鉴定胰腺导管腺癌的新型蛋白质标志物

2024-04-121
OAAI
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets (vol 24, pg 1540, 2023)
2023-09-076
OAAI
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
2023-08-10207
OAAI
Rare and common genetic determinants of metabolic individuality and their effects on human health

代谢个性的罕见和常见遗传决定因素及其对人类健康的影响

2022-11-1055
OAAI
Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke
2022-10-1725
OAAI
Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study
2021-11-216
OAAI
Whole-genome sequencing in diverse subjects identifies genetic correlates of leukocyte traits: The NHLBI TOPMed program

不同受试者的全基因组测序确定白细胞性状的遗传相关性: NHLBI TOPMed计划

2021-10-0118
OAAI
Whole genome sequence analysis of platelet traits in the NHLBI Trans-Omics for Precision Medicine (TOPMed) initiative

NHLBI精准医学跨组学 (TOPMed) 计划中血小板性状的全基因组序列分析

2021-09-0614
OA
Whole-genome sequencing association analysis of quantitative red blood cell phenotypes: The NHLBI TOPMed program (vol 108, pg 874, 2021)
2021-06-018
OAAI
Whole-genome sequencing association analysis of quantitative red blood cell phenotypes: The NHLBI TOPMed program

定量红细胞表型的全基因组测序关联分析: NHLBI TOPMed程序

2021-05-0126
OAAI